Controlled Release from Porous Platforms
Pharmaceutical Technology Europe
The authors present a method for controlling the release of therapeutics by applying a plasma polymer layer to the surface of porous materials.
By Spomenka Simovic, Dusan Losic and Krasimir Vasilev
The authors present a method for controlling the release of therapeutics by applying a plasma polymer layer to the surface of porous materials. The current study applied this technique to the release of antibiotics and a protein. The approach substantially reduced the initial burst release and provided zero-order release kinetics. The method can be applied to any type of porous drug carrier because the techniques for depositing a polymer overlayer are independent of the substrate.
This article was also published in our US sister publication Pharmaceutical Technology and can be read here.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
